183 related articles for article (PubMed ID: 21166881)
1. GPI-anchored protein-deficient T cells in patients with aplastic anemia and low-risk myelodysplastic syndrome: implications for the immunopathophysiology of bone marrow failure.
Katagiri T; Qi Z; Ohtake S; Nakao S
Eur J Haematol; 2011 Mar; 86(3):226-36. PubMed ID: 21166881
[TBL] [Abstract][Full Text] [Related]
2. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
[TBL] [Abstract][Full Text] [Related]
3. The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells.
Pu JJ; Hu R; Mukhina GL; Carraway HE; McDevitt MA; Brodsky RA
Haematologica; 2012 Aug; 97(8):1225-33. PubMed ID: 22315493
[TBL] [Abstract][Full Text] [Related]
4. Individual hematopoietic stem cells in human bone marrow of patients with aplastic anemia or myelodysplastic syndrome stably give rise to limited cell lineages.
Katagiri T; Kawamoto H; Nakakuki T; Ishiyama K; Okada-Hatakeyama M; Ohtake S; Seiki Y; Hosokawa K; Nakao S
Stem Cells; 2013 Mar; 31(3):536-46. PubMed ID: 23316019
[TBL] [Abstract][Full Text] [Related]
5. Increased glycosylphosphatidylinositol-anchored protein-deficient granulocytes define a benign subset of bone marrow failures in patients with trisomy 8.
Hosokawa K; Sugimori N; Katagiri T; Sasaki Y; Saito C; Seiki Y; Mochizuki K; Yamazaki H; Takami A; Nakao S
Eur J Haematol; 2015 Sep; 95(3):230-8. PubMed ID: 25404431
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure.
Hosokawa K; Sugimori C; Ishiyama K; Takamatsu H; Noji H; Shichishima T; Obara N; Chiba S; Ninomiya H; Shirasugi Y; Nakamura Y; Ando K; Ueda Y; Yonemura Y; Kawaguchi T; Nishimura JI; Kanakura Y; Nakao S
Ann Hematol; 2018 Dec; 97(12):2289-2297. PubMed ID: 30039297
[TBL] [Abstract][Full Text] [Related]
7. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
8. Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations.
Battiwalla M; Hepgur M; Pan D; McCarthy PL; Ahluwalia MS; Camacho SH; Starostik P; Wallace PK
Cytometry B Clin Cytom; 2010 Sep; 78(5):348-56. PubMed ID: 20533383
[TBL] [Abstract][Full Text] [Related]
9. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.
Ware RE; Pickens CV; DeCastro CM; Howard TA
Exp Hematol; 2001 Dec; 29(12):1403-9. PubMed ID: 11750098
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.
Hosokawa K; Ishiyama K; Ikemoto T; Sugimori C; Noji H; Shichishima T; Obara N; Chiba S; Ninomiya H; Nguyen MAT; Shirasugi Y; Nakamura Y; Ando K; Ueda Y; Yonemura Y; Kawaguchi T; Nishimura JI; Kanakura Y; Nakao S
Ann Hematol; 2021 Aug; 100(8):1975-1982. PubMed ID: 33095337
[TBL] [Abstract][Full Text] [Related]
11. Impact of immunogenetic polymorphisms in bone marrow failure syndromes.
Serio B; Selleri C; Maciejewski JP
Mini Rev Med Chem; 2011 Jun; 11(6):544-52. PubMed ID: 21561401
[TBL] [Abstract][Full Text] [Related]
12. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
[TBL] [Abstract][Full Text] [Related]
13. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
Shichishima T; Noji H
Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
[TBL] [Abstract][Full Text] [Related]
14. A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.
Raza A; Ravandi F; Rastogi A; Bubis J; Lim SH; Weitz I; Castro-Malaspina H; Galili N; Jawde RA; Illingworth A
Cytometry B Clin Cytom; 2014 May; 86(3):175-82. PubMed ID: 24227693
[TBL] [Abstract][Full Text] [Related]
15. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link.
Griscelli-Bennaceur A; Gluckman E; Scrobohaci ML; Jonveaux P; Vu T; Bazarbachi A; Carosella ED; Sigaux F; Socié G
Blood; 1995 Mar; 85(5):1354-63. PubMed ID: 7858265
[TBL] [Abstract][Full Text] [Related]
16. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.
Wang SA; Pozdnyakova O; Jorgensen JL; Medeiros LJ; Stachurski D; Anderson M; Raza A; Woda BA
Haematologica; 2009 Jan; 94(1):29-37. PubMed ID: 19001281
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
Maciejewski JP; Young NS; Yu M; Anderson SM; Sloand EM
Thromb Res; 1996 Sep; 83(6):433-47. PubMed ID: 8885138
[TBL] [Abstract][Full Text] [Related]
18. Paroxysmal nocturnal haemoglobinuria: a replacement of haematopoietic tissue?
Schrezenmeier H; Hildebrand A; Rojewski M; Häcker H; Heimpel H; Raghavachar A
Acta Haematol; 2000; 103(1):41-8. PubMed ID: 10705158
[TBL] [Abstract][Full Text] [Related]
19. Clonal Cell Proliferation in Paroxysmal Nocturnal Hemoglobinuria: Evaluation of
Park J; Kim M; Kim Y; Han K; Chung NG; Cho B; Lee SE; Lee JW
Ann Lab Med; 2019 Sep; 39(5):438-446. PubMed ID: 31037862
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
Townsley DM; Desmond R; Dunbar CE; Young NS
Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
